KRAS and non-small cell lung carcinoma: Two studies of Asian patients with NSCLC [41, 42], as well as meta- and pooled analyses [43, 44], demonstrated that the presence of KRAS mutations is a poor prognostic factor in Asians with NSCLC, while its relationship to prognosis in cases of NSCLC in non-Asian patients is still debatable.